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Multiple epiphyseal dysplasia, an autosomal domi­
nant disease, is among the more common inherited 
osteochondrodysplasias. Symptoms range from 
stiffness and pain in large joints to frank osteoarthri­
tis associated with short stature and stubby fin­
gers1’ 7. Linkage analyses of multiple epiphyseal 
dysplasia families suggest at least three loci. One 
locus, EDM1, maps to chromosome 19 (ref. 4), and 
is caused by mutations in cartilage oligomeric 
matrix protein (COMP)8. Mutations in COMP have 
also been identified in patients with pseudoachon- 
droplasia (PSACH)8,9, consistent with previous 
analyses which suggested that EDM1 and PSACH 
could be allelic disorders10. A second locus, 
EDM2, maps to chromosome 1 in the vicinity of the 
COL9A2 gene6, Finally, exclusion of EDM1 and 
EDM2 in other families suggests the existence of at 
least one additional locus11. We now show that 
affected members of a large kindred with multiple 
epiphyseal dysplasia linked to the EDM2 locus are 
heterozygous for a splice site mutation within 
COL9A2, causing exon skipping during RNA splic­
ing and an in-frame loss of 12 amino acid residues 
within the a2(IX) collagen chain. The results pro­
vide the first in vivo evidence for the role of collagen 
IX in human articular cartilage.
Clinical features in part of the present family have been 
previously reported12,13. Affected individuals typically 
presented during childhood and adolescence with wad­
dling gait and stiffness and/or pain in the knees, Few 
patients experienced involvement of other joints such as 
the elbow, wrist, or ankle. No one complained of hip or 
shoulder pain. Some patients were mildly short statured 
and/or had stubby hands. Several patients never sought 
medical advice because of the mildness of their com­
plaints. There were no spine abnormalities. X-rays 
revealed flattened, irregular epiphyses (Fig. 1 ), varus/val­
gus deformity of the knees, and gradually appearing 
osteoarthritis with or without loose bodies. Since family 
members did not have complaints about their hips, 
X-rays of hips are limited to only a few cases. In these 
cases (including the patient whose knees are shown in 
Fig. 1) a variable phenotype is seen, ranging from almost 
normal for age to slight irregularity of epiphyseal surface
and acetabulum.
Linkage analysis was performed with microsatellite 
markers from the EDM1 {Dl9Sl99y D19S212, D19S215i 
D19S222) and EDM2 {DIS186 and MYCL) regions4*6. 
The EDM I locus was excluded (data not shown), where­
as significant linkage was observed between the disorder
Fig. 1 X-rays of the 
right and left knee 
joints of an 11 
years 9 months old 
affected boy in the 
Dutch family. Note 
irregular ossifica­
tion and flattening 
of epiphyses.
and the EDM2 locus. The maximal lod score z = 15.31 
was obtained with the marker MYCL at 0 = 0.016, based 
upon one recombination event occurring in an affected 
individual.
To look for the causative mutation we first used the 
reverse transcription-polymerase chain reaction 
(RT-PCR). The RNA source was either total RNA from 
short term cultured chondrocytes (obtained during 
arthroscopic surgery) or Epstein-Barr virus (EBV) trans­
formed lymphoblasts from an affected patient. An unaf­
fected individual’s lymphoblasts were used as control. 
Nested PCR reactions amplified overlapping cDNA frag­
ments encoding the NC2, COL2, NC3, and COL3 
domains and the carboxyl half of the signal peptide of 
the cx2(IX) collagen chain, Fig, 2 shows a schematic rep­
resentation of the collagen components in cartilage col­
lagen fibrils. Fragments of cDNA encoding the NCI and 
COL1 domains were amplified without nesting. Elec­
trophoretic separation of the RT-PCR products of the 
COL3 domain (obtained with nested primers 7/9 and 
the more closely spaced primers, 7/13) showed migra­
tion as a single appropriately sized fragment in the con­
trol individual, whereas the affected individual had two 
fragments of equal intensity (Fig. 3c), The abnormally 
sized fragment was eluted from the gel and subjected to 
cycle sequence analysis. This revealed an in-frame dele­
tion of 36 nucleotides when compared to the wild-type 
sequence (data not shown).
The sequence of the 36 nucleotide deletion corresponds 
to a single exon encoding the N-tcrminal region of the 
COL3 domain of the a2(IX) collagen polypeptide (Fig. 
31;). Amplification of genomic DNA with PCR primers 
that represented exons flanking the deleted sequence 
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Fig. 2 The collagen components in cartilage collagen fibrils, The 
fibrillar collagens II and XI form the body of the fibril while the 
FACIT21 molecule, collagen IX, is located on the fibril surface. 
Each of the three polypeptide subunits of collagen IX contains 
three triple-helical domains (straight lines) interrupted by 
non-triple-helical domains (bold vertical cross-bars). The a1(lX) 
chain contains a large N-terminal globular domain (NC4); a chon- 
droitin sulfate (CS) chain is attached to the a2(IX) chain. A flexible 
kink in the CS-attachment region allows a portion of the molecule 
to project from the fibril surface into the perifibrillar space.
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Genotyping and linkage analysis. Genomic DNA was prepared 
from venous blood23. Genotyping for each of the selected markers 
was performed by PCR amplification using 50 ng DNA and 30 ng 
of the appropriate primers (Genome DataBase, Isogen Bioscience, 
the Netherlands) in 15 )ll amplification mixture (10 mM Tris-HCJ 
pH  9.0, 50 mM KCl, 1.5 mM MgCl2, 0.1% Triton X-100, 0.0 1% 
(w/v) gelatin, 200 pM of each dATP, dCTP, dTTP and 2.5 pM 
dCTP) with 0.06 U SuperTaq DNA polymerase (HT Biotechnolo­
gy). During the 30 cycles of DNA amplification (1 min at 94 °C, 2 
min at 55 °C and 1 min at 72 °C), 0.6 pCi a 32P-dCTP (10 mCi/ml, 
3000 Ci/mmol) was included. Samples were analysed on 6.6% 
denaturing polyacrylamide gels. Allelic bands were visualized by 
overnight exposure of dried gels to Kodak X-OMAT S film. Link­
age analyses were performed using the MLINK and ILINK options 
of the program package LINKAGE, version 5.10 (ref. 24). Full 
penetrance was assumed for the disorder, whereas the disease gene 
frequency was estimated at 0 .0001. The allele frequencies of the 
genetic markers were obtained from the Genome Database.
Analysis o f  the  COL9A2 gene. RNA was extracted from 
EBV-transformed lymphoblasts and cultured chondrocytes by 
the acid guanidinium thiocyanate/phenol/chloroform method25. 
First strand cDNAs were synthesized with oligo(dT) primers 
using the Superscript Preamplification System (G1BCO BRL). 
PCR primers were designed to amplify the ~2-kb cDNA in four 
overlapping fragments. The second round PCR used nested 
primers. For amplification for the first round PCR, 35 cycles were 
performed at 94 °C for 0.5 min, 62 °C for 1 min, and 72 °C for 2 
min, followed by an additional extension step at 72 °C for 10 min. 
The second round PCR was the same except that the annealing 
temperature was 58 °C. The sets of primers used were as follows 
(sense and antisense): 9A2-5, S'-CTCCAGGTGGTAGTGCTC- 
GCT-3' and 9A2-2, 5'-GGCTTCCCGCTTGGCACTCAC-3'; 
9A2- 1 1 , 5'-GCCACTGACCAGCACATCGTG-3' and 9A2-12,
5 -T C  A AG G C C CCTTG TAG G ATC C -3 '; 9A2-7, S'-CTGGCG- 
CAGATTAGAGGTCCA-3’ and 9A2-9, S’-ATGCCCCTTCAC- 
TCCCTGCAG-3’; 9A2-1, 5-GCGGATTTCCTGTGTCCAA- 
C C -3 ’ and 9A2-6, 5'-AGAGAATCCAGGAAGGCCCTG-3‘; 
9A2-10, 5 -CACCAGGGCCTAGCGGGTGTG“ 3' and 9A2-4, 
5’-GGCGACCTCTGCCAGTTGCTC-3'. The primer pairs 5/2 
and 11/12 were used for first round PCR. The product obtained 
with the pair 1 1 / 1 2  was analysed without further amplification.
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The product obtained with the pair 5/2 was amplified further by 
using primer pairs 7/9, 1 /6, and 10/4 for second round PCR. All 
PCR reactions were done in a total volume of 50 pi containing 1 
X PCR buffer, 200 pM  dNTP, 0.5 pM (each) primer and 1U of Taq 
polymerase. The PCR products were analysed on 2% agarose 
gels. All products were the same size from affected and unaffect­
ed individuals except the product obtained with primer pair 7/9. 
This product migrated as a single band from unaffected individ­
uals and as a double band from affected individuals. 
Dideoxy-nucleotide cycle sequencing (ampliCycle™, Perkin 
Elmer), showed a 36 nt deletion in the lower band. To better 
analyse this deletion, an additional anti-sense primer 9A2-13, 
5'~CAATCCCGGGCTTCCCGTCTG-3' (closer than primer 9 to 
primer 7) was made and used for second round PCR with the 
9A2-7 primer. PCR condition was 35 cycles at 94 °C for 0.5 min, 
58 °C for 1 min, 72 °C for 2 min and additional 72 °C for 10 min 
at the end of cycles; 0.5 pi of [a~33P] dCTP (10 mM, 2000 
Ci/mmol) was added to the reaction. The product obtained with 
primers 7/13 was analysed on a 5% sequencing gel and subjected 
to cycle sequencing as well. For amplifying genomic DNA, two 
additional sense primers 9A2-14, 5-CCTGGATCCGACGGCA' 
TCGAC-31 and 9A2-16, 5-CAATGGGCCCCCTGGAAAAGC-3' 
were synthesized and the primer pairs 14/13 and 16/13 were used 
for PCR. The conditions were heating at 95 °C for 0.5 min, 64 °C 
for 1 min, and at 72 °C for 2 min, with a final extension at 72 °C 
for 10 min. These amplification products were also cycle 
sequenced. The products obtained with primers 16/13 from 
genomic DNA of 79 members of the family were digested with 
Hphl and analysed on 4% agarose gels. The primers were syn­
thesized on the basis of both published26 and unpublished 
sequences. The original GenBank/EMBL file (accession number 
M95610) has been updated to include the additional unpublished 
sequences.
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